LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/5% of Ortho Surgery Patients Become Long Term Opioid Users?
Spine

5% of Ortho Surgery Patients Become Long Term Opioid Users?

February 28, 2020 1 min read Premium comments

Advertisement

5% of Ortho Surgery Patients Become Long Term Opioid Users?
Source: Wikimedia Commons and Lt. Cmdr. Jesse Ehrenfeld
Secondary#orthopedicsurgery#opioiduse

As the opioid crisis continues to rage on, more attention is being paid to the role surgeons play in unintentionally setting their patients on the road to long-term use of opioid prescriptions.

In, “New Long-Term Opioid Prescription-Filling Behavior Arising in the 15 Months After Orthopaedic Surgery,” published in The Journal of Bone and Joint Surgery on February 19, 2020, researchers investigated the risk of new long-term opioid prescription-filling behavior after orthopedic surgery.

Using data from the Virginia All-Payer Claims Database, the researchers found that 5.3% (95% CI, 5.1% to 5.5%) of those patients who had not touched opioids in the year before surgery started taking them on a long-term basis after orthopedic surgery.

The highest rates were found in patients who underwent a spinal procedure. Anterior cruciate ligament reconstruction patients had the lowest rates. In addition, these behaviors were more likely after a revision procedure than a primary one (p < 0.05). The increased complexity of the surgery was also a risk factor.

The researchers said that orthopedic surgeons need to be aware of the risk for new long-term opioid prescription-filling behavior after surgery.

In an accompanying editorial, “Does Orthopaedic Surgery Often Cause New Chronic Opioid Use?” Jacques T. YaDeau, M.D., Ph.D., wrote that this study should have an impact on the informed consent process.

“Shouldn’t patients know if many similar patients transition to chronic opioid use? It is common practice during informed consent to disclose the risks of complications such as infection or nerve damage that may occur much less frequently,” he said.

“It is incumbent on hospitals and physicians who perform high risk surgical procedures to determine the incidence of new long-term opioid use. Hospitals and physicians must then undertake measures to prevent patients from transitioning from opioid-free to opioid-dependent.”

He added that future research should focus on ways to reduce opioid doses and limit duration of use after surgery, including making changes to surgical techniques and finding alternative analgesics.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy